Second- and third-generation beta-blocking drugs in chronic heart failure

Cardiovascular Drugs and Therapy

Volumn 11, Issue SUPPL. 1, 1997, Pages 291-296

  Bristow, Michael R ^a   Abraham, William T ^a   Yoshikawa, Tsutomu ^a   White, Michel ^a   Hattler, Brack G ^a   Crisman, Thomas S ^a   Lowes, Brian D ^a   Robertson, A D ^a   Larrabee, Patti ^b   Gilbert, Edward M ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Antiadrenergic activity; Beta blocking drugs; Chronic heart failure; Exercise response; Idiopathic dilated cardiomyopathy; Ischemic cardiomyopathy; Left ventricular function

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUCINDOLOL; CARVEDILOL; METOPROLOL;

ADRENERGIC ACTIVITY; ADULT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERABILITY; EXERCISE; FEMALE; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; CARBAZOLES; CARDIAC OUTPUT, LOW; CARDIOMYOPATHY, DILATED; CHRONIC DISEASE; EXERCISE TEST; HEART VENTRICLES; HEMODYNAMIC PROCESSES; HUMANS; METOPROLOL; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OXYGEN CONSUMPTION; PROPANOLAMINES; VENTRICULAR FUNCTION, LEFT;

EID: 8244249474     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007748131847     Document Type: Article

References (16)

1. Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993;342:1441-1446.
2. CIBIS Investigators. A randomized trial of beta-blockade in heart failure: The cardiac insufficiency bisoprolol study (CIBIS). Circulation 1994;90:1765-1773.
3. Bristow MR, O'Connell JB Gilbert EM, et al. for the Bucindolol Investigators. Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Circulation 1994;89:1632-1642.
4. Olsen SL, Gilbert EM, Renlund DG, Taylor DO, Yanowitz FD, Bristow MR. Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized study. J Am Coll Cardiol 1995;25:1225-1231.
5. Krum H, Sackner-Bernstein JD, Goldsmith RL, et al. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation 1995;92:1499-1506.
6. Bristow MR, Gilbert EM, Abraham WT, et al. for the MOCHA investigators. Multicenter oral carvedilol heart failure assessment (MOCHA): A six-month dose-response evaluation in class II-IV patients. Circulation 1995;92:(Supple I)142-000.
7. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB. Effect of carvedilol on the survival of patients with chronic heart failure. Circulation 1995;92:(Supple I)142-000.
8. Hershberger RE, Wynn JR, Sundberg L, Bristow MR. Mechanism of action of bucindolol in human ventricular myocardium. J Cardiovasc Pharmacol 1990;15:959-967.
9. Yoshikawa T, Port JD, Asano K, et al. Cardiac adrenergic receptor effects of carvedilol. Eur Heart J 1996; 17(Supple R):8-16.
10. Metra M, Nardi M, Giubbini R, DeiCas L. Effects of short-and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1994;24:1678-1687.
11. Di Lenarda A, Gilbert EM, Olsen SL, Mealey PC, Bristow MR. Acute hemodynamic effects of carvedilol versus metoprolol in idiopathic dilated cardiomyopathy (abstract) J Am Coll Cardiol 1991;17:142.
12. Eichhorn DJ, Bedotto JB, Malloy CR, et al. Effect of sadrenergic blockade on myocardial function and energetics in congestive heart failure. Circulation 1990;82:473-483.
13. Bristow MR, Gilbert EM. Improvement in cardiac myocyte function by biological effects of medical therapy: A new concept in the treatment of heart failure. Eur Heart J 1995;16;(Supple F):20-31.
14. Anderson JL, Gilbert EM, O'Connell JB, et al. Long-term (2 year) beneficial effects of beta-adrenergic blockage with bucindolol in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1991;17:1373-1381.
15. Hall SA, Cigarroa CG, Marcoux L, Risser RC, Grayburn PA, Eichhorn EJ. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol 1995;25:1154-1161.
16. Bristow MR, Olson S, Gilbert EM, et al. β-blockade with carvedilol selectively lowers cardiac adrenergic drive in the failing human heart (abstr). J Am Coll Cardiol 1992;19:146.